Time trends in systemic thrombolysis in a large hospital-based stroke registry

Cerebrovascular Diseases

Volumn 33, Issue 4, 2012, Pages 316-321

  Singer, O C ^a   Hamann, G F ^b   Misselwitz, B ^c   Steinmetz, H ^a   Foerch, C ^a  

^a GOETHE UNIVERSITY   (Germany)

^b DR HORST SCHMIDT KLINIKEN   (Germany)

^c Geschaftsstelle Qualitatssicherung Hessen   (Germany)

Author keywords

Acute stroke therapy; Aging; Systemic thrombolysis

Indexed keywords

ALTEPLASE;

AGED; ARTICLE; BLOOD CLOT LYSIS; DISABILITY; DISEASE REGISTRY; FIBRINOLYTIC THERAPY; HOSPITAL ADMISSION; HUMAN; PRIORITY JOURNAL; PROSPECTIVE STUDY; STROKE; TIME;

AGE FACTORS; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; BRAIN ISCHEMIA; COHORT STUDIES; DISABILITY EVALUATION; FEMALE; FIBRINOLYTIC AGENTS; GERMANY; HOSPITALS; HUMANS; INTERNATIONAL CLASSIFICATION OF DISEASES; MALE; MIDDLE AGED; REGISTRIES; STROKE; THROMBOLYTIC THERAPY; TIME FACTORS; TISSUE PLASMINOGEN ACTIVATOR;

EID: 84856938289     PISSN: 10159770     EISSN: 14219786     Source Type: Journal    
DOI: 10.1159/000335816     Document Type: Article

References (14)

1. NINDS tPA Study Group: Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995; 333: 1581-1587.
2. Foerch C, Misselwitz B, Sitzer M, Berger K, Steinmetz H, Neumann-Haefelin T: Difference in recognition of right and left hemispheric stroke. Lancet 2005; 366: 392-393. (Pubitemid 41073957)
3. Foerch C, Misselwitz B, Sitzer M, Steinmetz H, Neumann-Haefelin T: The projected burden of stroke in the German federal state of Hesse up to the year 2050. Dtsch Arztebl Int 2008; 105: 467-473.
4. Stolz E, Hamann GF, Kaps M, Misselwitz B: Regional differences in acute stroke admission and thrombolysis rates in the German federal state of Hesse. Dtsch Arztebl Int 2011; 108: 607-611.
5. Adeoye O, Hornung R, Khatri P, Kleindorfer D: Recombinant tissue-type plasminogen activator use for ischemic stroke in the united states: a doubling of treatment rates over the course of 5 years. Stroke 2011; 42: 1952-1955.
6. Mishra NK, Ahmed N, Andersen G, Egido JA, Lindsberg PJ, Ringleb PA, Wahlgren NG, Lees KR: Thrombolysis in very elderly people: controlled comparison of SITS International Stroke Thrombolysis Registry and Virtual International Stroke Trials Archive. BMJ 2010; 341:c6046.
7. Bhatnagar P, Sinha D, Parker RA, Guyler P, O'Brien A: Intravenous thrombolysis in acute ischaemic stroke: a systematic re-view and meta-analysis to aid decision making in patients over 80 years of age. J Neurol Neurosurg Psychiatry 2011; 82: 712-717.
8. Ford GA, Ahmed N, Azevedo E, Grond M, Larrue V, Lindsberg PJ, Toni D, Wahlgren N: Intravenous alteplase for stroke in those older than 80 years old. Stroke 2010; 41: 2568-2574.
9. Mishra NK, Diener HC, Lyden PD, Bluhmki E, Lees KR: Influence of age on outcome from thrombolysis in acute stroke: a controlled comparison in patients from the Virtual International Stroke Trials Archive (VISTA). Stroke 2010; 41: 2840-2848.
10. Wahlgren N, Ahmed N, Davalos A, Ford GA, Grond M, Hacke W, Hennerici MG, Kaste M, Kuelkens S, Larrue V, Lees KR, Roine RO, Soinne L, Toni D, Vanhooren G: Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study. Lancet 2007; 369: 275-282. (Pubitemid 46138121)
11. Hacke W, Kaste M, Bluhmki E, Brozman M, Davalos A, Guidetti D, Larrue V, Lees KR, Medeghri Z, Machnig T, Schneider D, von Kummer R, Wahlgren N, Toni D: Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med 2008; 359: 1317-1329.
12. Guidelines for management of ischaemic stroke and transient ischaemic attack 2008. Cerebrovasc Dis 2008; 25: 457-507.
13. Molina CA, Alvarez-Sabin J, Montaner J, Abilleira S, Arenillas JF, Coscojuela P, Romero F, Codina A: Thrombolysis-related hemorrhagic infarction: a marker of early reperfusion, reduced infarct size, and improved outcome in patients with proximal middle cerebral artery occlusion. Stroke 2002; 33: 1551-1556. (Pubitemid 34619956)
14. Thomalla G, Sobesky J, Kohrmann M, Fiebach JB, Fiehler J, Zaro Weber O, Kruetzelmann A, Kucinski T, Rosenkranz M, Rother J, Schellinger PD: Two tales: hemorrhagic transformation but not parenchymal hemorrhage after thrombolysis is related to severity and duration of ischemia: MRI study of acute stroke patients treated with intravenous tissue plasminogen activator within 6 h. Stroke 2007; 38: 313-318. (Pubitemid 46184301)